TWiV 1008: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses variant specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on omicron VOC, ventilation in buildings, COVID-19 mortality among selective serotonin reuptake inhibitor users, risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses, trajectories of the evolution of post COVID-19 condition, and efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Virus variant clinical performance of a SARS-CoV-2 rapid antigen test (CID)
• Ventilation in buildings (CDC)
• COVID-19 mortality among SSRI users (CMI)
• Risk of post-acute sequelae of SARS-CoV-2 infection associated with sleep apnea (SLEEP)
• Trajectories of the evolution of post COVID-19 condition (IJID)
• Efficacy of cognitive behavioral therapy targeting fatigue following COVID-19 (CAD)
• Contribute to our FIMRC fundraiser at PWB
• Letters read on TWiV 1008
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [email protected]